[1] Ramsay, I., Kaur, S. and Krassas, G. (1983) Thyrotoxicosis in Pregnancy: Results of Treatment by Antithyroid Drugs Combined with T4. Clinical Endocrinology (Oxford), 18, 73-85.
http://dx.doi.org/10.1111/j.1365-2265.1983.tb03188.x
[2] McKenzie, J.M. and Zakarija, M. (1992) Fetal and Neonatal Hyperthyroidism and Hypothyroidism Due to Maternal TSH Receptor Antibodies. Thyroid, 2, 155-159.
http://dx.doi.org/10.1089/thy.1992.2.155
[3] Sunshine, P., Kusumoto, H. and Kriss, J.P. (1965) Survival Time of Circulating Long-Acting Thyroid Stimulator in Neonatal Thyrotoxicosis: Implications for Diagnosis and Therapy of the Disorder. Pediatrics, 36, 869-876.
[4] Smallridge, R.C., Wartofsky, L., Chopra, I.J., Marinelli, P.V., Broughton, R.E., Dimond, R.C., et al. (1978) Neonatal Thyrotoxicosis: Alterations in Serum Concentrations of LATS-Protector, T4, T3, Reverse T3, and 3, 3’T2. Journal of Pediatrics, 93, 118-120.
http://dx.doi.org/10.1016/S0022-3476(78)80620-9
[5] Volpé, R., Ehrlich, R., Steiner, G. and Row, V.V. (1984) Graves’ Disease in Pregnancy Years after Hyperthyroidism with Recurrent Passive-Transfer Neonatal Graves’ Disease in Offspring. Therapeutic Considerations. American Journal of Medicine, 77, 572-578.
http://dx.doi.org/10.1016/0002-9343(84)90125-6
[6] Peleg, D., Cada, S., Peleg, A. and Ben-Ami, M. (2002) The Relationship between Maternal Serum Thyroid-Stimulating Immunoglobulin and Fetal and Neonatal Thyrotoxicosis. Obstetrics Gynecology, 99, 1040-1043.
http://dx.doi.org/10.1016/S0029-7844(02)01961-0
[7] Farrehi, C. (1968) Accelerated Maturity in Fetal Thyrotoxicosis. Clinical Pediatrics, 7, 134-137.
http://dx.doi.org/10.1177/000992286800700304
[8] Radetti, G., Zavallone, A., Gentili, L., Beck-Peccoz, P. and Bona, G. (2002) Foetal and Neonatal Thyroid Disorders. Minerva Pediatrica, 54, 383-400.
[9] Zimmerman, D. (1999) Fetal and Neonatal Hyperthyroidism. Thyroid, 9, 727-733.
http://dx.doi.org/10.1089/thy.1999.9.727
[10] Daneman, D. and Howard, N.J. (1980) Neonatal Thyrotoxicosis: Intellectual Impairment and Craniosynostosis in Later Years. Journal of Pediatrics, 97, 257-259.
http://dx.doi.org/10.1016/S0022-3476(80)80487-2
[11] Zakarija, M., McKenzie, J.M. and Hoffman, W.H. (1986) Prediction and Therapy of Intrauterine and Late-Onset Neonatal Hyperthyroidism. The Journal of Clinical Endocrinology & Metabolism, 62, 368-71.
http://dx.doi.org/10.1210/jcem-62-2-368
[12] Hung, W. and Sarlis, N. (2004) Autoimmune and Non-Autoimmune Hyperthyroidism in Pediatric Patients. Pediatric Endocrinology Reviews, 2, 21-38.
[13] Fong, T.L., McHutchison, J.G. and Reynolds, T.B. (1992) Hyperthyroidism and Hepatic Dysfunction. A Case Series Analysis. Journal of Clinical Gastroenterology, 14, 240-244.
http://dx.doi.org/10.1097/00004836-199204000-00010
[14] Skelton, M. (1955) Congenital Thyrotoxicosis, Hepatosplenomegaly and Jaundice in Two Infants of Exophthalmic Mothers. Archives of Disease in Childhood, 30, 460-464.
http://dx.doi.org/10.1136/adc.30.153.460
[15] Farber, S. and Craig, J. (1959) Clinical Pathological Conference: The Children’s Medical Center Boston, Mass. Journal of Pediatrics, 54, 829-837.
http://dx.doi.org/10.1016/S0022-3476(59)80154-2
[16] Hollinsworth, D. and Mabry, C.C. (1976) Congenital Graves Disease. Four Familial Cases with Long-Term Follow-Up and Perspective. American Journal of Diseases of Children, 130, 148-155.
http://dx.doi.org/10.1001/archpedi.1976.02120030038008
[17] Neal, P.R., Jansen, R.D., Lemons, J.A., Mirkin, L.D. and Schreiner, R.L. (1985) Unusual Manifestation of Neonatal Hyperthyroidism. American Journal of Perinatology, 2, 231-235.
http://dx.doi.org/10.1055/s-2007-999957
[18] Cove, D. and Johnston, P. (1985) Fetal Hyperthroidim: Experience of Treatment in Four Siblings. The Lancet, 1, 430-432.
http://dx.doi.org/10.1016/S0140-6736(85)91148-1
[19] Singer, J. (1977) Neonatal Thyrotoxicosis. Journal of Pediatrics, 91, 749-751.
http://dx.doi.org/10.1016/S0022-3476(77)81028-7
[20] Polak, M. (1998) Hyperthyroidism in Early Infancy: Pathogenesis, Clinical Features and Diagnosis with a Focus on Neonatal Hyperthyroidism. Thyroid, 12, 1171-1177.
http://dx.doi.org/10.1089/thy.1998.8.1171
[21] Page, D.V., Brady, K., Mitchell, J., Pehrson, J. and Wade, G. (1988) The Pathology of Intrauterine Thyrotoxicosis: Two Case reports. Obstetrics & Gynecology, 72, 479-481.
[22] Beroukhim, R.S., Moon, T.D. and Felner, E.I. (2003) Neonatal Thyrotoxicosis and Conjugated Hyperbilirubinemia. Journal of Maternal-Fetal and Neonatal Medicine, 13, 426-428.
http://dx.doi.org/10.1080/jmf.13.6.426.428
[23] Dryden, C., Simpson, J.H., Hunter, L.E. and Jackson, L. (2007) An Unusual Cause of Neonatal Coagulopathy and Liver Disease. Journal of Perinatology, 27, 320-322.
http://dx.doi.org/10.1038/sj.jp.7211687
[24] Loomba-Albrecht, L.A., Bremer, A.A., Wong, A. and Philipps, A.F. (2012) Neonatal Cholestasis Caused by Hyperthyroidism. Journal of Pediatric Gastroenterology and Nutrition, 54, 433-434.
http://dx.doi.org/10.1097/MPG.0b013e318228f9a8
[25] Karpen, S.J. (2002) Update on the Etiologies and Management of Neonatal Cholestasis. Clinics in Perinatology, 29,159-180.
http://dx.doi.org/10.1016/S0095-5108(03)00069-1
[26] Venigalla, S. and Gourley, G.R. (2004) Neonatal Cholestasis. Seminars in Perinatology, 28, 348-355.
http://dx.doi.org/10.1053/j.semperi.2004.09.008
[27] Moyer, V., Freese, D.K., Whitington, P.F., Olson, A.D., Brewer, F., Colletti, R.B., et al. (2004) North American Society for Pediatric Gastroenterology, Hepatology and Nutrition.Guideline for the Evaluation of Cholestatic Jaundice in infants: Recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. Journal of Pediatric Gastroenterology and Nutrition, 39, 115-128.
http://dx.doi.org/10.1097/00005176-200408000-00001
[28] Myers, J.D., Brannon, E.S. and Holland, B.C. (1950) Correlative Study of the Cardiac Output and the Hepatic Circulation in Hyperthyroidism. Journal of Clinical Investigation, 29, 1069-1077.
http://dx.doi.org/10.1172/JCI102338
[29] Yao, J.D., Gross Jr., J.B., Ludwig, J. and Purnell, D.C. (1989) Cholestatic Jaundice and Hyperthyroidism. American Journal of Medicine, 86, 619-620.
http://dx.doi.org/10.1016/0002-9343(89)90398-7
[30] Hayashida, C.Y., Duarte, A.J.S., Sato, A.E. and E Yamashiro-Kanashiro.H. (1990) Neonatal Hepatitis and Lymphocyte Sensitization by Placental Transfer of Prpylthiouracil. Journal of Endocrinological Investigation, 13, 937-941.
http://dx.doi.org/10.1007/BF03349663
[31] Deidiker, R. and de Mello, D.E. (1996) Propythiouracil-Induced Fulminant Hepatitis: Case Report Review of the Literature. Pediatric Pathology & Laboratory Medicine, 16, 845-852.
http://dx.doi.org/10.3109/15513819609169310
[32] Foley, T. (1991) Maternally Transferred Thyroid Disease in the Infant: Recognition and Treatment. Advances in Perinatal Thyroidology, 299, 209-226.
http://dx.doi.org/10.1007/978-1-4684-5973-9_12